SBIR/STTR Research Award

Creating a bioluminescent mouse model for fast screening of drugs

Award identifier 5ae6ca79f2fe849464d542cbd23a38ae16dfc51743e9b842a33f6544c0f62e02Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$217,130

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Theramix LLC
Proposal award date
2017-08-15
Contract end date
2019-02-14
UEI
NPYUSJHF5KS9
Solicitation number
PA13-092
Topic code
100

Research abstract

Abstract We propose an easy way to quickly generate reporter mice without genetic manipulation of animals for the application in the drug development The generated reporter mice performs like transgenic mice which have ubiquitously embedded reporters that are needed to monitor a particular cellular or molecular process over an extended time frame Also the attachment of reporters to mice don t interfere with naturally occurring processes This proposal aims to examine a reporter system consisting of our reporter mice and a newly discovered imaging biomarker to address the challenges in creating a universal biomarker imaging for monitoring efficacy and safety of drugs By using the new reporter system we have successfully detected dynamic cellular responses to drugs in toxicological models We expect to establish a general imaging protocol for quick assessing efficacy and toxicity of drugs through the study of this proposal Public Health Relevance The success of this proposal would bring a simple way of generating reporter mice and its related imaging technology into drug discovery to accelerate the development process The new reporter system will make it possible to fast screening of drugs in animals It will break the limitation of cell based drug testing in which the simplified cellular system hardly recapitulate the actual physiological environment and is difficult to screen against targets in the cellular microenvironment The ability to direct screening drugs in animals would significantly expend drugable targets and create more efficient therapeutics

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $693,873. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.